Revenue: The sum of all revenue fields included for a company's operating activities.
Sage Therapeutics, Inc. (SAGE) had Revenue of $41.24M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$41.24M |
$-400.67M |
|
$9.44M |
|
$31.80M |
|
$473.61M |
|
$-432.37M |
|
$31.70M |
|
$-400.67M |
|
$-400.67M |
|
$-400.67M |
|
$-400.67M |
|
$-400.67M |
|
$-400.67M |
|
$-432.37M |
|
$-437.82M |
|
60.77M |
|
60.77M |
|
$-6.59 |
|
$-6.59 |
|
| Balance Sheet Financials | |
$531.30M |
|
$0.89M |
|
$15.92M |
|
$547.22M |
|
$71.61M |
|
-- |
|
$10.52M |
|
$82.13M |
|
$465.09M |
|
$465.09M |
|
$465.09M |
|
61.36M |
|
| Cash Flow Statement Financials | |
$-267.19M |
|
$266.68M |
|
$10.66M |
|
$72.32M |
|
$82.47M |
|
$10.15M |
|
$54.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
77.10% |
|
-1048.35% |
|
-1048.35% |
|
-1061.56% |
|
-971.48% |
|
-971.48% |
|
$-267.19M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
4.52 |
|
80.84 |
|
-86.15% |
|
-86.15% |
|
-73.22% |
|
-86.15% |
|
$7.58 |
|
$-4.40 |
|
$-4.40 |
|